Evidence map›Paper›PMID 26284068›Full record

ArticleFrontiers in immunology2015

eIF2α Confers Cellular Tolerance to S. aureus α-Toxin.

Gisela von Hoven, Claudia Neukirch, Martina Meyenburg, Sabine Füser, Maria Bidna Petrivna, Amable J Rivas, Alexey Ryazanov, Randal J Kaufman, Raffi V Aroian, Matthias Husmann

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Gisela von HovenUniversity Medical Center, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg-University , Mainz , Germany.
Claudia NeukirchUniversity Medical Center, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg-University , Mainz , Germany.
Martina MeyenburgUniversity Medical Center, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg-University , Mainz , Germany.
Sabine FüserUniversity Medical Center, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg-University , Mainz , Germany.
Maria Bidna PetrivnaUniversity Medical Center, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg-University , Mainz , Germany.
Amable J RivasUniversity Medical Center, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg-University , Mainz , Germany.
Alexey RyazanovDepartment of Pharmacology, Rutgers Robert Wood Johnson Medical School , Piscataway, NJ , USA.
Randal J KaufmanDegenerative Diseases Program, Sanford-Burnham Medical Research Institute , La Jolla, CA , USA.
Raffi V AroianUniversity of Massachusetts Medical School , Worcester, MA , USA.
Matthias HusmannUniversity Medical Center, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg-University , Mainz , Germany.
Johannes Gutenberg University Mainz · DE

Funding

Regulation of Factor VIII SecretionR01HL052173 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 1995 to 2014
$6.5M
Role of the Unfolded Protein Response in Beta CellR37DK042394 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2007 to 2016
$4.9M
Regulation of ER stress-induced cell deathR01DK088227 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2010 to 2014
$3.1M
p38-mediated defense pathway against pore-forming toxinsR01GM071603 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AROIAN, RAFFI V · 2006 to 2014
$2.5M
Unfolded Protein Response in Glucose HomeostasisR01DK042394 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2003 to 2006
$1.2M
NHLBI NIH HHS R01 HL052173NIDDK NIH HHS R01 DK042394NIDDK NIH HHS R01 DK088227NIDDK NIH HHS R37 DK042394NIGMS NIH HHS R01 GM071603
6 · The paper itself

Abstract

We report on the role of conserved stress-response pathways for cellular tolerance to a pore forming toxin. First, we observed that small molecular weight inhibitors including of eIF2α-phosphatase, jun-N-terminal kinase (JNK), and PI3-kinase sensitized normal mouse embryonal fibroblasts (MEFs) to the small pore forming S. aureus α-toxin. Sensitization depended on expression of mADAM10, the murine ortholog of a proposed high-affinity receptor for α-toxin in human cells. Similarly, eIF2α (S51A/S51A) MEFs, which harbor an Ala knock-in mutation at the regulated Ser51 phosphorylation site of eukaryotic translation initiation factor 2α, were hyper-sensitive to α-toxin. Inhibition of translation with cycloheximide did not mimic the tolerogenic effect of eIF2α-phosphorylation. Notably, eIF2α-dependent tolerance of MEFs was toxin-selective, as wild-type MEFs and eIF2α (S51A/S51A) MEFs exhibited virtually equal sensitivity to Vibrio cholerae cytolysin. Binding of S. aureus α-toxin to eIF2α (S51A/S51A) MEFs and toxicity in these cells were enhanced as compared to wild-type cells. This led to the unexpected finding that the mutant cells carried more ADAM10. Because basal phosphorylation of eIF2α in MEFs required amino acid deprivation-activated eIF2α-kinase 4/GCN2, the data reveal that basal activity of this kinase mediates tolerance of MEFs to α-toxin. Further, they suggest that modulation of ADAM10 is involved. During infection, bacterial growth may cause nutrient shortage in tissues, which might activate this response. Tolerance to α-toxin was robust in macrophages and did not depend on GCN2. However, JNKs appeared to play a role, suggesting differential cell type and toxin selectivity of tolerogenic stress responses. Understanding their function or failure will be important to comprehend anti-bacterial immune responses.

Indexed as

cellular toleranceEIF2AK4MAPKpore forming toxinsS. aureus α-toxin

Identifiers

PMID26284068
PMCPMC4515601
OpenAlexW1571305584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.